AcelRx Pharma (ACRX)

3.63 -0.52 (12.53%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/8/18 *Est.)

Latest Headlines

AcelRx Pharma (ACRX) Comments Following Positive FDA Advisory Committee Meeting October 19, 2018 3:16 PM - StreetInsider AcelRx Provides Updated Comments Following Positive FDA Advisory Committee Meeting October 19, 2018 3:15 PM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Oct 15 Filed by: Hamel Lawrence G October 16, 2018 4:32 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Oct 15 Filed by: Dasu Badri N October 16, 2018 4:30 PM - SEC Filing DSUVIA Efficacy and Safety Data to be Presented at the American Society of Anesthesiologists (ASA) Annual Conference October 15, 2018 4:01 PM - PR NewsWire AcelRx Pharmaceuticals (ACRX) PT Raised to $8 at H.C. Wainwright October 15, 2018 12:27 PM - StreetInsider Pre-Open Movers 10/15: (ACRX) (ABCD) (LLL) Higher; (SHLD) (NTRI) Lower (more...) October 15, 2018 9:22 AM - StreetInsider Jefferies Upgrades AcelRx Pharmaceuticals (ACRX) to Buy October 15, 2018 6:09 AM - StreetInsider AcelRx Pharma (ACRX) Confirms FDA Advisory Committee Recommends Approval of DSUVIA for Treatment of Moderate-To-Severe Acute Pain October 12, 2018 4:16 PM - StreetInsider FDA Advisory Committee Recommends Approval Of DSUVIA For The Treatment Of Moderate-To-Severe Acute Pain October 12, 2018 4:15 PM - PR NewsWire AcelRx Pharma's (ACRX) Pain-Killer Dsuvia Wins FDA Panel Backing, Vote 10-3 to Support Approval - Bloomberg October 12, 2018 2:53 PM - StreetInsider AcelRx Pharma (ACRX) Stock Trading Halted Ahead of FDA Advisory Committee to Review DSUVIA NDA October 12, 2018 7:11 AM - StreetInsider AcelRx Pharmaceuticals Stock Trading Halted; FDA Advisory Committee to Review DSUVIA New Drug Application October 12, 2018 7:10 AM - PR NewsWire AcelRx Pharma (ACRX) Halted, News Pending October 12, 2018 6:55 AM - StreetInsider AcelRx (ACRX) Briefing Docs Bode Well for Vote - H.C. Wainwright October 10, 2018 12:30 PM - StreetInsider AcelRx (ACRX) Briefing Docs 'Positive', Expect Favorable Vote - Oppenheimer October 10, 2018 12:24 PM - StreetInsider AcelRx Pharmaceuticals (ACRX) PT Raised to $10 at Ladenburg Thalmann October 10, 2018 9:56 AM - StreetInsider AcelRx (ACRX) Could Have Positive AdCom Vote - Cantor Fitzgerald October 10, 2018 9:45 AM - StreetInsider AcelRx Pharma (ACRX) shares on watch as FDA briefing docs released October 10, 2018 8:05 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Sep 24 Filed by: Hamel Lawrence G September 26, 2018 5:55 PM - SEC Filing AcelRx Pharmaceuticals to Present at Two Upcoming Investor Conferences in October September 25, 2018 4:05 PM - PR NewsWire AcelRx Pharma (ACRX) Announces Date of FDA Advisory Committee Meeting for DSUVIA September 11, 2018 7:02 AM - StreetInsider AcelRx Announces Date of FDA Advisory Committee Meeting for DSUVIA™ September 11, 2018 7:00 AM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Aug 31 Filed by: Dasu Badri N September 5, 2018 6:11 AM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Aug 31 Filed by: ASADORIAN RAFFI September 5, 2018 6:09 AM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Aug 31 Filed by: Angotti Vincent J. September 5, 2018 6:08 AM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Aug 31 Filed by: Hamel Lawrence G September 5, 2018 6:08 AM - SEC Filing AcelRx Pharmaceuticals to Participate at Two Upcoming Investor Events in September August 23, 2018 4:05 PM - PR NewsWire AcelRx Pharmaceuticals to Present at the 2018 Military Health System Research Symposium August 20, 2018 7:00 AM - PR NewsWire Ladenburg Thalmann Starts AcelRx Pharmaceuticals (ACRX) at Buy August 16, 2018 6:49 AM - StreetInsider Form 4 ACELRX PHARMACEUTICALS For: Aug 07 Filed by: EDWARDS MARK G August 8, 2018 4:39 PM - SEC Filing AcelRx Pharmaceuticals Announces Full Exercise of Underwriters' Option to Purchase Additional Shares August 8, 2018 7:00 AM - PR NewsWire Form 4 ACELRX PHARMACEUTICALS For: Aug 07 Filed by: Angotti Vincent J. August 7, 2018 4:16 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Aug 06 Filed by: Palmer Pamela P August 6, 2018 5:39 PM - SEC Filing Form 4 ACELRX PHARMACEUTICALS For: Aug 06 Filed by: ASADORIAN RAFFI August 6, 2018 5:24 PM - SEC Filing Form 10-Q ACELRX PHARMACEUTICALS For: Jun 30 August 2, 2018 5:21 PM - SEC Filing Form 8-K ACELRX PHARMACEUTICALS For: Aug 02 August 2, 2018 4:07 PM - SEC Filing AcelRx Pharma (ACRX) Reports In-Line Q2 EPS August 2, 2018 4:05 PM - StreetInsider AcelRx Pharmaceuticals Reports Second Quarter 2018 Financial Results August 2, 2018 4:01 PM - PR NewsWire Full Article List